WC
OGEN icon

Wexford Capital’s Oragenics OGEN Stock Holding History

Wexford Capital’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-333
Closed – – 126
2018
Q3 		$0 Buy
+333
New +$384K ﹤0.01% 163

Other funds holding OGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HWM
Holloway Wealth Management Gainesville, Florida $350M AUM 10.13% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wexford Capital's OGEN Position: Q4 2018 in Review

Wexford Capital sold out of Oragenics (OGEN) in Q4 2018, closing a stake of 333 shares.

Wexford Capital first reported a position in OGEN in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 11 funds tracked by Wall St. Rank hold OGEN as of Q4 2018.

  • Wexford Capital reported no remaining Oragenics position as of Q4 2018 after selling out during the quarter.
  • Wexford Capital sold 333 Oragenics shares in Q4 2018.
  • Wexford Capital first reported a position in Oragenics in Q3 2018 and held it in 1 quarter.
  • Wexford Capital's Oragenics position peaked at $0 in Q3 2018.
  • 11 funds tracked by Wall St. Rank held Oragenics as of Q4 2018.

Based on Wexford Capital's 13F filing for Q4 2018, filed 14 Feb 2019.